(Q34028620)

30 July 2017

1 reference

title

Vasopeptidase inhibition: a new direction in cardiovascular treatment (English)

1 reference

30 July 2017

1 reference

J R Asher

1

1 reference

PubMed ID

10981174

30 July 2017

A J Naftilan

series ordinal

2

1 reference

30 July 2017

1 August 2000

1 reference

Current Hypertension Reports

30 July 2017

1 reference

30 July 2017

2

1 reference

30 July 2017

4

1 reference

30 July 2017

384-391

1 reference

https://scigraph.springernature.com/pub.10.1007/s11906-000-0042-y

30 July 2017

0 references

cites work

Antihypertensive efficacy of treatment regimens used in Veterans Administration hypertension clinics. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents

1 reference

https://api.crossref.org/works/10.1007%2FS11906-000-0042-Y

Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-000-0042-Y

Differential regional expression of three natriuretic peptide receptor genes within primate tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-000-0042-Y

Comparison of candoxatril and atrial natriuretic factor in healthy men. Effects on hemodynamics, sympathetic activity, heart rate variability, and endothelin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-000-0042-Y

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

21 January 2018

1 reference

12 December 2020

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

12 December 2020

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

1 reference

12 December 2020

Urodilatin, a natriuretic factor from kidneys, can modify renal and cardiovascular function in men

1 reference

12 December 2020

Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg

1 reference

12 December 2020

1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee

1 reference

12 December 2020

Vasopeptidase inhibition: a new concept in blood pressure management

1 reference

12 December 2020

Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg

1 reference

12 December 2020

Sustained antihypertensive actions of a dual angiotensin-converting enzyme neutral endopeptidase inhibitor, sampatrilat, in black hypertensive subjects.

1 reference

12 December 2020

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

12 December 2020

A new member of the natriuretic peptide family is present in the venom of the green mamba (Dendroaspis angusticeps)

1 reference

12 December 2020

Ongoing clinical trials of angiotensin-converting enzyme inhibitors for treatment of coronary artery disease in patients with preserved left ventricular function

1 reference

12 December 2020

Characterization of neutral endopeptidase in vascular cells, modulation of vasoactive peptide levels

1 reference

12 December 2020

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

1 reference

12 December 2020

Physiological role of silent receptors of atrial natriuretic factor

1 reference

12 December 2020

Effect of inhibition of endopeptidase 24.11 on responses to angiotensin II in human volunteers

1 reference

12 December 2020

Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

1 reference

12 December 2020

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

12 December 2020

Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries

1 reference

12 December 2020

Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function

1 reference

12 December 2020

C-type natriuretic peptide: the endothelial component of the natriuretic peptide system.

1 reference

12 December 2020

Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators

1 reference

12 December 2020

Emerging treatments for hypertension: potential role for vasopeptidase inhibition

1 reference

12 December 2020

Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP)

1 reference

12 December 2020

Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study

1 reference

12 December 2020

Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones

1 reference

12 December 2020

Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension

1 reference

12 December 2020

Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme BMS-182657 in experimental hypertension and heart failure.

1 reference

12 December 2020

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

12 December 2020

Acute inhibition of endopeptidase 24.11 in essential hypertension: SCH 34826 enhances atrial natriuretic peptide and natriuresis without lowering blood pressure

1 reference

12 December 2020

The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)

1 reference

12 December 2020

1 reference

12 December 2020

Candoxatril, a neutral endopeptidase inhibitor: efficacy and tolerability in essential hypertension

1 reference

12 December 2020

Renal response to acute neutral endopeptidase inhibition in mild and severe experimental heart failure

1 reference

12 December 2020

Effects of a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100,240, on endocrine and renal functions in healthy volunteers

1 reference

12 December 2020

A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats

1 reference

12 December 2020

Chronic dual inhibition of angiotensin-converting enzyme and neutral endopeptidase during the development of left ventricular dysfunction in dogs

1 reference

12 December 2020

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

12 December 2020

Endopeptidase-24.11 and its inhibitors: potential therapeutic agents for edematous disorders and hypertension

1 reference

12 December 2020

Effect of long-term therapy with fasidotril, a mixed inhibitor of neprilysin and angiotensin-converting enzyme (ACE), on survival of rats after myocardial infarction

1 reference

12 December 2020

A rationale for treatment of endothelial dysfunction in hypertension

1 reference

12 December 2020

Dual metalloprotease inhibitors: mercaptoacetyl-based fused heterocyclic dipeptide mimetics as inhibitors of angiotensin-converting enzyme and neutral endopeptidase

1 reference

12 December 2020

Antihypertensive activity during inhibition of neutral endopeptidase and angiotensin converting enzyme

1 reference

12 December 2020

Effects of omapatrilat in low, normal, and high renin experimental hypertension

1 reference

12 December 2020

10.1007/S11906-000-0042-Y

Identifiers

DOI

1 reference

PubMed ID

10981174

Dimensions Publication ID

30 July 2017

0 references

1 reference

PubMed ID

10981174